s'authentifier
version française rss feed
Profiling target genes of FGF18 in the postnatal mouse lung: possible relevance for alveolar development.
Franco-Montoya M.-L., Boucherat O., Thibault C., Chailley-Heu B., Incitti R., Delacourt C., Bourbon J. R.
Physiological Genomics 43, 21 (2011) 1226-40 - http://www.hal.inserm.fr/inserm-00647306
 (21878612) 
Profiling target genes of FGF18 in the postnatal mouse lung: possible relevance for alveolar development.
Marie-Laure Franco-Montoya () 1, 2, Olivier Boucherat3, Christelle Thibault4, Bernadette Chailley-Heu1, Roberto Incitti1, Christophe Delacourt1, 2, Jacques Bourbon1, 2
1 :  Institut Mondor de Recherche Biomédicale
INSERM : U955 – Université Paris-Est Créteil Val-de-Marne (UPEC) – IFR10
8 rue du Général Sarrail, 94010 Créteil
France
2 :  PremUP
PremUP – Université Paris V - Paris Descartes
Paris
France
3 :  Centre de Recherche en Cancérologie
Université Laval
Centre Hospitalier Universitaire de Québec, L'Hôtel-Dieu de Québec
Canada
4 :  IGBMC - Institut de Génétique et de Biologie Moléculaire et Cellulaire
http://www.igbmc.fr/
INSERM : U964 – CNRS : UMR7104 – Université de Strasbourg
Parc D'Innovation 1 Rue Laurent Fries - BP 10142 67404 Illkirch Cedex
France
FGF18 target genes in postnatal lung
Better understanding alveolarization mechanisms could help improve prevention and treatment of diseases characterized by reduced alveolar number. Although signaling through fibroblast growth factor (FGF) receptors is essential for alveolarization, involved ligands are unidentified. FGF18, the expression of which peaks coincidentally with alveolar septation, is likely to be involved. Herein, a mouse model with inducible, lung-targeted FGF18 transgene was used to advance the onset of FGF18 expression peak, and genome-wide expression changes were determined by comparison with littermate controls. Quantitative RT-PCR was used to confirm expression changes of selected up- and downregulated genes and to determine their expression profiles in the course of lung postnatal development. This allowed identifying so-far unknown target genes of the factor, among which a number are known to be involved in alveolarization. The major target was adrenomedullin, a promoter of lung angiogenesis and alveolar development, whose transcript was increased 6.9-fold. Other genes involved in angiogenesis presented marked expression increases, including Wnt2 and cullin2. Although it appeared to favor cell migration notably through enhanced expression of Snai1/2, FGF18 also induced various changes consistent with prevention of epithelial-mesenchymal transition. Together with antifibrotic effects driven by induction of E prostanoid receptor 2 and repression of numerous myofibroblast markers, this could prevent alveolar septation-driving mechanisms from becoming excessive and deleterious. Last, FGF18 up- or downregulated genes of extracellular matrix components and epithelial cell markers previously shown to be up- or downregulated during alveolarization. These findings therefore argue for an involvement of FGF18 in the control of various developmental events during the alveolar stage.
Sciences du Vivant/Biochimie, Biologie Moléculaire
Anglais
1094-8341

Articles dans des revues avec comité de lecture
10.1152/physiolgenomics.00034.2011
Physiological Genomics (Physiol Genomics)
Publisher American Physiological Society
ISSN 1094-8341 (eISSN : 1531-2267)
internationale
07/11/2011
30/08/2011
43
21
1226-40

transgenic mice – alveolarization – angiogenesis – fibrosis – epithelial-mesenchymal transition.
Liste des fichiers attachés à ce document : 
PDF
39629_2_merged_1314194800.pdf(540 KB)
inserm-00647306_edited.pdf(518.5 KB)
XHTML
index.xhtml(96.4 KB)

tous les articles de la base du CCSd...